1,10-phenanthroline has been researched along with Alloxan Diabetes in 1 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eizirik, DL | 1 |
| de Lúcio, MA | 1 |
| Boschero, AC | 1 |
| Hoffmann, ME | 1 |
1 other study available for 1,10-phenanthroline and Alloxan Diabetes
| Article | Year |
|---|---|
1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
Topics: Alloxan; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Hydroxides; Hydroxyl Radical; Ir | 1986 |